EdgarLookup

Aligos Therapeutics, Inc. — SC 13G/A Filings

21 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Aligos Therapeutics, Inc. (ALGS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aligos Therapeutics, Inc. has filed 21 SC 13G/A documents with the SEC since 2020. To view all SEC filings by Aligos Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 3 4 424B3 424B4 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS EFFECT PRE 14A S-1 S-1/A S-3 S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC TO-C SC TO-I SC TO-I/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-24-098622 Nov 14, 2024 —
SC 13G/A — 0000935836-24-000723 Nov 14, 2024 —
SC 13G/A — 0001172661-24-005305 Nov 14, 2024 —
SC 13G/A — 0001172661-24-005266 Nov 14, 2024 —
SC 13G/A ALIGOS THERAPEUTICS, INC. 0000902664-24-006624 Nov 14, 2024 —
SC 13G/A — 0000935836-24-000204 Feb 14, 2024 —
SC 13G/A ALIGOS THERAPEUTICS, INC. 0000902664-24-001727 Feb 14, 2024 —
SC 13G/A SC 13G/A 0001104659-24-023723 Feb 14, 2024 —
SC 13G/A AMENDMENT NO. 2 0001214659-24-002858 Feb 14, 2024 —
SC 13G/A SC 13G/A 0001104659-23-115332 Nov 7, 2023 —
SC 13G/A ALIGOS THERAPEUTICS, INC. 0000902664-23-001809 Feb 14, 2023 —
SC 13G/A AMENDMENT NO. 1 0001214659-23-002389 Feb 14, 2023 —
SC 13G/A — 0000935836-23-000115 Feb 13, 2023 —
SC 13G/A SC 13G/A 0001193125-23-028518 Feb 8, 2023 —
SC 13G/A — 0000935836-22-000175 Feb 14, 2022 —
SC 13G/A ALIGOS THERAPEUTICS, INC. 0000902664-22-001723 Feb 14, 2022 —
SC 13G/A SC 13G/A 0001193125-22-034471 Feb 10, 2022 —
SC 13G/A SC 13G/A 0001193125-22-034455 Feb 10, 2022 —
SC 13G/A SEC SCHEDULE 13G 0000902219-22-000013 Feb 10, 2022 —
SC 13G/A SEC SCHEDULE 13G 0001678858-22-000101 Feb 4, 2022 —
SC 13G/A SEC SCHEDULE 13G 0001678858-22-000043 Feb 4, 2022 —